a, a N Clinical Trials

A listing of a, a N clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1959 clinical trials
Effects of a Multimodal Exercise Program on Physical Performance and Muscle Function in Middle-aged Patients With T2DM  

Background Middle-aged individuals with T2DM, especially in Asian populations, face a heightened risk of sarcopenia. This condition leads to a decline in muscle mass and function, which negatively impacts their quality of life.

  • 0 views
  • 02 Dec, 2025
  • 3 locations
A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19

A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of pulsed inhaled iNO compared to placebo in subjects with COVID-19.

pneumonia
treatment regimen
covid-19
SARS
ct scan
  • 0 views
  • 19 Feb, 2024
  • 14 locations
A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy

A study of CTA101 UCAR-T cell injection in patients with relapsed or refractory CD19+ B-line hematological malignancy

diffuse large b-cell lymphoma
hematologic malignancy
lymphoma
follicular lymphoma
autologous hematopoietic stem cell transplant
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

This is an open-label, dose escalation study to evaluate the safety, toxicity, and pharmacokinetics (PK) as well as preliminary efficacy of BTX-A51 capsules in participants with relapsed or refractory acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS). The study will be done in two phases. Phase 1a of this …

leukemia
refractory acute myeloid leukemia (aml)
refractory aml
myeloid leukemia
myelodysplastic syndromes
  • 0 views
  • 19 Feb, 2024
  • 1 location
KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated Nonsquamous NSCLC

KEAP1/NRF2 mutation status (for eligibility) and STK11/LKB1 status (for stratification) will be determined by next generation sequencing. A commercial liquid biopsy (circulating tumor DNA) NGS test will be provided to study participants free of charge.

proto-oncogene tyrosine-protein kinase ros
metastasis
EGFR
BRAF
pembrolizumab
  • 0 views
  • 19 Feb, 2024
  • 28 locations
A Study to Evaluate the Safety Tolerability and Immunogenicity of Tau Targeted Vaccines in Participants With Early Alzheimer's Disease

This study is a multicenter, double blind, randomized, placebo-controlled study to evaluate the safety, tolerability and immunogenicity of different doses, regimens and combinations of Tau targeted vaccines in participants with early Alzheimer's Disease.

mild cognitive impairment
cognitive impairment
amyloid
memantine
alzheimer's disease
  • 0 views
  • 19 Feb, 2024
  • 6 locations
A Study to Look at How Safe NNC0472-0147 is in Healthy People and in People With Type 2 Diabetes

Participants will get once daily injections of either NNC0472-0147 or insulin glargine for a treatment period of fourteen days. The injections will be given under the skin (subcutaneously, s.c.) of the left thigh. Participants will be in the study for about 7 weeks.

diabetes
type 2 diabetes mellitus
low density lipoprotein
bilateral salpingectomy
oophorectomy
  • 0 views
  • 19 Feb, 2024
  • 2 locations
Systematic Radioiodine Administration (3.7 GBq I131 After rhTSH) Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up

This trial is comparing two strategies in intermediate-risk differentiated thyroid cancer patients: Systematic radioiodine administration (3.7 GBq I131 after rhTSH) versus decision of radioiodine treatment guided by a post-operative work-up based on serum Tg values and diagnostic RAI scintigraphy

thyroglobulin
rtsh
metastasis
papillary thyroid carcinoma
follicular thyroid carcinoma
  • 0 views
  • 19 Feb, 2024
  • 1 location
Evaluation of a Virtual Reality Tool for Identifying the Cognitive Functions of the Right Hemisphere in Patients With Glioma -TANGO

Evaluate the diagnostic performance of a virtual reality application to detect the presence of cognitive impairment of the non-dominant hemisphere in patients with glioma

cognitive impairment
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET

A Phase II trial aiming to assess the safety and activity of the combination of cabozantinib plus lanreotide in gastroenteropancreatic (GEP) and thoracic neuroendocrine tumor (NET): The LOLA trial

24-hour urine protein test
thromboembolic event
activated partial thromboplastin time
international normalized ratio
peripheral vascular disease
  • 0 views
  • 19 Feb, 2024
  • 1 location